Pierre Champagne

Neovastat (?-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis

Daniel N. Sauder, Joel G. DeKoven, Pierre Champagne et al. · Journal of the American Academy of Dermatology · 2002 · 64 citations

Medicine, Clinical Sciences, Pharmacology +7

Prognostic Factors of Metastatic Renal Cell Carcinoma After Failure of Immunotherapy: New Paradigm From a Large Phase III Trial With Shark Cartilage Extract AE 941

Bernard Escudier, Toni K. Choueiri, Stéphane Oudard et al. · The Journal of Urology · 2007 · 63 citations

Medicine, Oncology, Pharmacology +17

Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer

Jean Latreille, Gerald Batist, Francis Laberge et al. · Clinical Lung Cancer · 2003 · 56 citations

Medicine, Oncology, Pharmacology +9

Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer

Fernand Labrie, Pierre Champagne, Claude Labrie et al. · Journal of Clinical Oncology · 2004 · 35 citations

Medicine, Oncology, Pharmacology +17